Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia (Q64375929)
Jump to navigation
Jump to search
scientific article published on 30 October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia |
scientific article published on 30 October 2008 |
Statements
Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia (English)
Claes Karlsson
Jeanette Lundin
Eva Kimby
Ben Kennedy
Paul Moreton
Peter Hillmen
Anders Osterborg